Reviewing the latest Gross Domestic Product (GDP) report from Mexico, "the solid 3.1% q/q rise in Mexico’s GDP in Q4 meant that the economy had recouped over 70% of its losses from the first half of 2020," noted Capital Economics analysts.
"However, the recent surge in new COVID-19 cases will cause the recovery to grind to a halt in Q1. 11 of Mexico’s 32 states are now in the strictest ‘red’ tier of restrictions. Given the severe strains in the healthcare system, it’s likely that stringent lockdown measures will stay in place over the coming weeks, dragging down activity. We think that this near-term economic weakness, alongside subdued inflation, will prompt Banxico to resume its easing cycle with a 25bp rate cut, to 4.00%, at its next meeting in February."
"That said, we’re cautiously optimistic about the outlook further ahead. Mexico seems fairly well placed to benefit from the rollout of vaccines, and we assume that most restrictions will be eased in the second half of the year. The external sector will be boosted by a strong recovery in the US too. Accordingly, we expect growth of 5.5% this year, and 4.5% in 2022. (See Chart 1) These forecasts lie above the consensus."
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.